{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:50:21Z","timestamp":1793451021986,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.vaccine.2023.07.042","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T01:15:16Z","timestamp":1690334116000},"page":"5454-5460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Incremental effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia hospitalisation among Australian Indigenous children: A record linkage study"],"prefix":"10.1016","volume":"41","author":[{"given":"Alamgir","family":"Kabir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5075-0227","authenticated-orcid":false,"given":"Deborah","family":"Randall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony T.","family":"Newall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah C.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Jayasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parveen","family":"Fathima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bette","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather F.","family":"Gidding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.07.042_b0005","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/S2214-109X(18)30408-X","article-title":"Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis","volume":"7","author":"McAllister","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2023.07.042_b0010","unstructured":"World Health Organization. Pneumonia.World Health Organization, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/pneumonia. 2019; [Accessed March 12, 2021]."},{"key":"10.1016\/j.vaccine.2023.07.042_b0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0140-6736(09)60914-4","article-title":"Indigenous health part 1: determinants and disease patterns","volume":"374","author":"Gracey","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.07.042_b0020","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0140-6736(06)68773-4","article-title":"Indigenous health in Australia, New Zealand, and the Pacific","volume":"367","author":"Anderson","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.07.042_b0025","unstructured":"World Health Organization & United Nations Children's Fund (UNICEF). Ending preventable child deaths from pneumonia and diarrhoea by 2025 : the integrated global action plan for pneumonia and diarrhoea (GAPPD). Geneva: World Health Organization; 2013."},{"key":"10.1016\/j.vaccine.2023.07.042_b0030","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S2352-4642(19)30249-4","article-title":"Effectiveness of pneumococcal conjugate vaccine against hospital admissions for pneumonia in Australian children: a retrospective, population-based, record-linked cohort study","volume":"3","author":"Fathima","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.vaccine.2023.07.042_b0035","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1097\/INF.0000000000000082","article-title":"Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia","volume":"33","author":"Loo","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2023.07.042_b0040","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3201\/eid2706.204238","article-title":"Twenty-year public health impact of 7-and 13-valent pneumococcal conjugate vaccines in US children","volume":"27","author":"Wasserman","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.042_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-019-4119-8","article-title":"The impact of childhood pneumococcal vaccination on hospital admissions in England: a whole population observational study","volume":"19","author":"Shiri","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.042_b0050","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S2352-4642(20)30090-0","article-title":"Acute lower respiratory infections in Indigenous infants in Australia's Northern Territory across three eras of pneumococcal conjugate vaccine use (2006\u201315): a population-based cohort study","volume":"4","author":"Binks","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.vaccine.2023.07.042_b0055","article-title":"Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries","volume":"3","author":"Rudan","year":"2013","journal-title":"J Glob Health"},{"key":"10.1016\/j.vaccine.2023.07.042_b0060","unstructured":"Public Health England. Pneumococcal polysaccharide vaccine (PPV23) Patient Group Direction (PGD). https:\/\/www.england.nhs.uk\/north-east-yorkshire\/wp-content\/uploads\/sites\/49\/2020\/08\/PPV23.pdf. 2020; [Accessed 14 October 2021]."},{"key":"10.1016\/j.vaccine.2023.07.042_b0065","unstructured":"Centers for Disease Control and Prevention. Pneumococcal vaccination: what everyone should know. https:\/\/www.cdc.gov\/vaccines\/vpd\/pneumo\/public\/index.html. 2020; [Accessed 14 October 2021]."},{"key":"10.1016\/j.vaccine.2023.07.042_b0070","unstructured":"National Advisory Committee on Immunization (NACI). Re-immunization with polysaccharide 23-valent pneumococcal vaccine (Pneu-P-23). https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/re-immunization-with-polysaccharide-23-valent-pneumococcal-vaccine-pneu-p-23.html. 2016; [Accessed 14 October 2021]."},{"key":"10.1016\/j.vaccine.2023.07.042_b0075","unstructured":"New Zealand Ministry of Health. Immunisation handbook 2020. 16. Pneumococcal disease. https:\/\/www.health.govt.nz\/our-work\/immunisation-handbook-2020\/16-pneumococcal-disease#_ENREF_21_72. 2020; [Accessed 14 October 2021]."},{"key":"10.1016\/j.vaccine.2023.07.042_b0080","series-title":"The Australian immunisation handbook","author":"Australian Technical Advisory Group on Immunisation","year":"2018"},{"key":"10.1016\/j.vaccine.2023.07.042_b0085","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1093\/cid\/ciy993","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of all-cause pneumonia in adults aged \u226560 years: a population-based, retrospective cohort study","volume":"68","author":"Kolditz","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.042_b0090","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/jech.2010.122762","article-title":"Reduction in disparity for pneumonia hospitalisations between Australian Indigenous and non-Indigenous children","volume":"66","author":"Moore","year":"2012","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.vaccine.2023.07.042_b0095","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/cid\/cix923","article-title":"The impact of pneumococcal vaccination on bacterial and viral pneumonia in Western Australian children: record linkage cohort study of 469589 births, 1996\u20132012","volume":"66","author":"Fathima","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.042_b0100","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/cid\/civ429","article-title":"Pneumonia in elderly Australians: reduction in presumptive pneumococcal hospitalizations but no change in all-cause pneumonia hospitalizations following 7-valent pneumococcal conjugate vaccination","volume":"61","author":"Menzies","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.042_b0105","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1086\/651079","article-title":"Increased risk of hospitalization for acute lower respiratory tract infection among Australian indigenous infants 5\u201323 months of age following pneumococcal vaccination: a cohort study","volume":"50","author":"O'Grady","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.042_b0110","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1016\/j.vaccine.2015.10.089","article-title":"Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children","volume":"33","author":"Jayasinghe","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.07.042_b0115","unstructured":"National Center for Immunisation Research and Surveillance. History of vaccination in Australia.NCIRS, https:\/\/www.ncirs.org.au\/health-professionals\/history-immunisation-australia. 2020; [Accessed 16 May 2020]."},{"key":"10.1016\/j.vaccine.2023.07.042_b0120","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.vaccine.2018.03.058","article-title":"Effectiveness of a 3+0 pneumococcal conjugate vaccine schedule against invasive pneumococcal disease among a birth cohort of 1.4 million children in Australia","volume":"36","author":"Gidding","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.07.042_b0125","first-page":"1","article-title":"Probabilistic linkage of national immunisation and state-based health records for a cohort of 1.9 million births to evaluate Australia\u2019s childhood immunisation program","volume":"2","author":"Gidding","year":"2017","journal-title":"Int J Popul Data Sci"},{"key":"10.1016\/j.vaccine.2023.07.042_b0130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/1753-6405.12481","article-title":"Establishing a process for conducting cross-jurisdictional record linkage in Australia","volume":"40","author":"Moore","year":"2016","journal-title":"Aust N Z J Public Health"},{"key":"10.1016\/j.vaccine.2023.07.042_b0135","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.vaccine.2021.02.015","article-title":"Estimating pneumococcal vaccine coverage among Australian Indigenous children and children with medically at-risk conditions using record linkage","volume":"39","author":"Kabir","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.07.042_b0140","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/j.1839-4655.2014.tb00322.x","article-title":"Evidence for the use of an algorithm in resolving inconsistent and missing Indigenous status in administrative data collections","volume":"49","author":"Christensen","year":"2014","journal-title":"Aust J Soc Issues"},{"key":"10.1016\/j.vaccine.2023.07.042_b0145","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.5694\/j.1326-5377.1998.tb123473.x","article-title":"Introducing ICD-10-AM in Australian hospitals","volume":"169","author":"Roberts","year":"1998","journal-title":"Med J Aust"},{"key":"10.1016\/j.vaccine.2023.07.042_b0150","series-title":"The Australian immunisation handbook","author":"Australian Technical Advisory Group on Immunisation","year":"2022"},{"key":"10.1016\/j.vaccine.2023.07.042_b0155","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/INF.0000000000002407","article-title":"Long-term vaccine impact on invasive pneumococcal disease among children with significant comorbidities in a large Australian birth cohort","volume":"38","author":"Jayasinghe","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2023.07.042_b0160","unstructured":"SAS Institute Inc. SAS 9.4 [Computer software]. Author Cary, NC; 2013."},{"key":"10.1016\/j.vaccine.2023.07.042_b0165","series-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2020"},{"key":"10.1016\/j.vaccine.2023.07.042_b0170","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/INF.0b013e3182323ac2","article-title":"Induction of immunologic memory following primary vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in infants","volume":"31","author":"Knuf","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2023.07.042_b0175","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1016\/j.vaccine.2020.10.042","article-title":"Pneumococcal conjugate vaccine primes mucosal immune responses to pneumococcal polysaccharide vaccine booster in Papua New Guinean children","volume":"38","author":"Orami","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.07.042_b0180","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1016\/j.vaccine.2008.05.012","article-title":"Immunogenicity for 16 serotypes of a unique schedule of pneumococcal vaccines in a high-risk population","volume":"26","author":"Leach","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.07.042_b0185","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1016\/j.vaccine.2011.04.038","article-title":"Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months","volume":"29","author":"Russell","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.07.042_b0190","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/QCO.0b013e3283531b0f","article-title":"Use of pneumococcal polysaccharide vaccine in children: what is the evidence?","volume":"25","author":"Borrow","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.042_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082280","article-title":"High nasopharyngeal carriage of non-vaccine serotypes in Western Australian aboriginal people following 10 years of pneumococcal conjugate vaccination","volume":"8","author":"Collins","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.07.042_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41479-016-0015-9","article-title":"Aboriginal and non-Aboriginal children in Western Australia carry different serotypes of pneumococci with different antimicrobial susceptibility profiles","volume":"8","author":"Dunne","year":"2016","journal-title":"Pneumonia"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23008733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23008733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:28:53Z","timestamp":1759404533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23008733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":40,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0264410X23008733"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.07.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incremental effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia hospitalisation among Australian Indigenous children: A record linkage study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.07.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}